CLINICAL TRIALS PROFILE FOR ESZOPICLONE
✉ Email this page to a colleague
All Clinical Trials for Eszopiclone
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00120250 ↗ | Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder | Completed | Massachusetts General Hospital | Phase 4 | 2005-06-01 | The purpose of this study is to obtain data investigating the safety and efficacy of eszopiclone for the treatment of post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with eszopiclone treatment on neuroendocrine correlates of PTSD. The investigators hypothesize that eszopiclone will be significantly more effective than placebo and well tolerated for PTSD-related sleep disturbance, improvement in sleep will be associated with improvement in overall PTSD symptoms, and patients with PTSD-related sleep disturbances will have abnormal levels of stress hormones. |
NCT00167375 ↗ | Testing the Nocturnal Sleep Latency Profile in Primary Insomnia | Completed | American Academy of Sleep Medicine | 2005-01-01 | This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies. | |
NCT00167375 ↗ | Testing the Nocturnal Sleep Latency Profile in Primary Insomnia | Completed | Sunovion | 2005-01-01 | This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies. | |
NCT00167375 ↗ | Testing the Nocturnal Sleep Latency Profile in Primary Insomnia | Completed | University of Pittsburgh | 2005-01-01 | This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies. | |
NCT00235508 ↗ | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder | Completed | Sunovion | Phase 4 | 2005-06-01 | To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will receive an approved anxiolytic agent and will be randomized to nightly therapy with either eszopiclone or placebo. |
NCT00247624 ↗ | Improving Sleep and Psychological Functioning in People With Depression and Insomnia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2005-10-01 | This study will evaluate the safety and effectiveness of treatment with both a sleeping pill and antidepressant medication in improving sleep and psychological functioning in people with depression and insomnia. |
NCT00247624 ↗ | Improving Sleep and Psychological Functioning in People With Depression and Insomnia | Completed | Philips Healthcare | Phase 4 | 2005-10-01 | This study will evaluate the safety and effectiveness of treatment with both a sleeping pill and antidepressant medication in improving sleep and psychological functioning in people with depression and insomnia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Eszopiclone
Condition Name
Clinical Trial Locations for Eszopiclone
Trials by Country
Clinical Trial Progress for Eszopiclone
Clinical Trial Phase
Clinical Trial Sponsors for Eszopiclone
Sponsor Name